Pharmacy

 

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.
June 20, 2024

HBI News Round Up, 7th June 2024

In this HBI News Round Up, we look at the recent UK cyberattack that disrupted healthcare services at hospitals and GP clinics, Sweden's 'Care Recovery Plan', the plans for the Swedish island of Gotland propose the region become a pilot area for state intervention and Australia's five-year deal with pharmacists. 
June 7, 2024

Italy’s pharmacies to offer expanded range of services

A new draft bill has been proposed by the Italian government which will allow pharmacies to offer an expanded range of services including vaccinations, diagnostic tests and the ability to book outpatient visits to the hospital. 
March 22, 2024

UK pharmacists given green light to prescribe as primary care can’t cope

Pharmacists in the UK now have the right to prescribe for common ailments such as sore throats and earaches. In France, Ireland and Portugal pharmacists also have some prescribing rights and similar initiatives may be introduced in other European countries in the near future. Is this a solution to the GP workforce shortage? And will it be a good thing for private hospital and private primary care groups?
February 2, 2024

Ardian to buy France’s largest pharmacy chain and make it multinational

French PE firm Ardian has entered into exclusive negotiations to buy France's largest pharmacy chain, Aprium Pharmacie, from North American PE firm Sagard. Ardian plans to develop Aprium's advisory and digital offering, and to expand the group outside of France. We speak to Ardian's head of growth to find out more.
January 26, 2024

Aster DM sells majority stake in Gulf business for $1bn

Dubai-based listed hospital and pharmacy chain Aster DM is selling a majority 65% stake in its Gulf business for a shade over $1bn to a consortium led by PE investor Fajr Capital. HBI investigates the thinking behind the deal, what this means for the group's expansion plans, and looks at the future of the GCC market generally with the help of expert commentary. 
December 1, 2023

Fresenius: “We’re not selling”

Germany-based healthcare conglomerate Fresenius tells HBI it isn't currently looking to carve off parts of its business for sale, and despite mixed H1 results it sees plenty of opportunities for growth.
August 5, 2022
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us